Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia

Stephanie M. Perez, Li Chen, Daniel J. Lodge

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Clinical studies have reported differences in the incidence and severity of schizophrenia symptoms between male and female schizophrenia patients. Unfortunately, the cause of these differences is not currently known due, in part, to the fact that preclinical studies largely focus on male subjects. Dopamine neuron activity has been previously demonstrated to change across the estrous cycle, and may therefore be of relevance, as aberrant dopamine signaling is thought to underlie the positive symptoms of schizophrenia. Here we examine dopamine neuron activity across the estrous cycle in the MAM rodent model of schizophrenia. We demonstrate that the elevation in dopamine neuron activity, consistently observed in male MAM-treated rats, is most prominent during estrus and attenuated in met-estrus. Furthermore, this appears to be mediated, in part, by progesterone in the ventral hippocampus, as increases in dopamine neuron population activity (observed in estrus) were normalized by the intra-hippocampal administration of the progesterone receptor antagonist, mifepristone (but not the estrogen receptor antagonists, fulvestrant). Taken together, these data suggest that changes in dopamine system function occur across the estrous cycle in MAM-treated rats and may contribute to the differences in symptomatology between male and female schizophrenia patients.

Original languageEnglish (US)
Pages (from-to)88-97
Number of pages10
JournalPsychoneuroendocrinology
Volume47
DOIs
StatePublished - Sep 2014

Keywords

  • Dopamine
  • Estrous cycle
  • Hippocampus
  • Progesterone
  • Schizophrenia

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia'. Together they form a unique fingerprint.

Cite this